Ignite Creation Date:
2025-12-25 @ 3:46 AM
Ignite Modification Date:
2026-05-28 @ 10:43 AM
Study NCT ID:
NCT01682902
Status:
COMPLETED
Last Update Posted:
2017-01-09
First Post:
2012-08-31
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomised Trial Evaluating Continuous Subcutaneous Infusion of Formulations of NN1218 and NovoLog® in Subjects With Type 1 Diabetes
Sponsor:
Novo Nordisk A/S
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NN1218-3930
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None